Jedd Wolchok, director of the Meyer Cancer Center at Weill Cornell Medicine (Credit: Weill Cornell Medicine)
Exclusive: Parker Institute expands to Weill Cornell Medicine as it grows immunotherapy work
The Parker Institute for Cancer Immunotherapy has added Weill Cornell Medicine to its network of centers across the US, with a focus on cell therapy for solid tumors and prioritization of vaccine targets.
While the institute would not disclose the amount of funding, the Cornell site will carry on for five years with an opportunity to renew, according to newly-appointed director Jedd Wolchok. The group said it has distributed $260 million to member researchers to support scientific research at its centers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
